Astellas Highlights VEOZAH™ (fezolinetant) Data at the 2023 Annual Meeting of The Menopause Society

/PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") will share new pooled efficacy and safety analyses from the...

Related Keywords

Tokyo ,Japan ,United States ,Canada ,Canadian ,Risa Kagan ,Naoki Okamura ,Gloria Richard Davis ,Genevieve Neal Perry ,Barbara Depree ,Nanette Santoro ,Prnewswire Astellas Pharma Inc ,Menopause Society ,Head Of Biopharma Development ,Elsevier ,Astellas Pharma Inc ,Health Qual Life Outcomes ,Vice President ,Biopharma Development ,Associated With Menopause ,Prescribing Information ,Patient Product Information ,Area Approach ,Equal Life ,